Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
Pakistan Journal of Biological Sciences
  Year: 2017 | Volume: 20 | Issue: 3 | Page No.: 124-131
DOI: 10.3923/pjbs.2017.124.131
Antioxidant and Biological Activities of Proteinaceous Extract from Algerian Glycine max Plant
Nassima Soussi, Saad Moulay, Khaldoun Bachari and Yamina Benmiri

Abstract:
Objective: Glycine max is commonly used in Algeria for treatment of anemia deficiency and osteoporosis, it ranks first in terms of vegetal proteins. The experiment was aimed at characterizing the proteinaceous Glycine max extract and evaluating its antioxidant, biological and hematological potential. Methodology: Extraction of proteinaceous materials from Glycine max plant was undertaken using water and n-hexane as extracting media. The isolation of proteins from the crude materials was done, providing the use of ammonium sulfate. The Glycine max proteins were characterized by UV-visible and FT-IR spectroscopy and analyzed by SEM micrograph and x-ray diffraction (XRD). Rheological parameters G’ and G’’ were assessed. The isolated proteins were tested for their antioxidant, antimicrobial and hemagglutination activities. Results: There was a gelling effect of the protein extract which can be used as an alternative in principally made vaccines with its microbiological and antifungal activities. Conclusion: The proteinaceous extract from Algerian Glycine max would have a potential use in biomedical application.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    In vitro Antioxidant Activity and Profile of Polyphenol Compounds Extracts and their Fractions on Cacao Beans
How to cite this article:

Nassima Soussi, Saad Moulay, Khaldoun Bachari and Yamina Benmiri, 2017. Antioxidant and Biological Activities of Proteinaceous Extract from Algerian Glycine max Plant. Pakistan Journal of Biological Sciences, 20: 124-131.

DOI: 10.3923/pjbs.2017.124.131

URL: https://scialert.net/abstract/?doi=pjbs.2017.124.131

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 

       

       

Curve Bottom